Association of adjuvant chemotherapy regimen with serial CA-125 kinetics (KELIM framework) and progression-free survival after cytoreductive surgery for ovarian cancer: a retrospective cohort study

Ahmad Alwazzan, Hisham Nasief, Razan Amjad, Rayyan Hasanain, Huda Altoukhi, Zayd Jastaniah, Wael Y. Alsayed, Dahlia Mirdad, Reyouf Almughamsi, Abdulkareem Fayoumi, Humaira Waseem, Amber Hassan

Open source

DOI: 10.1515/oncologie-2025-0535
Published: 2026-03-01
Container: Oncologie
Publisher: Walter de Gruyter GmbH
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1515/oncologie-2025-0535,
  title = {Association of adjuvant chemotherapy regimen with serial CA-125 kinetics (KELIM framework) and progression-free survival after cytoreductive surgery for ovarian cancer: a retrospective cohort study},
  author = {Ahmad Alwazzan and Hisham Nasief and Razan Amjad and Rayyan Hasanain and Huda Altoukhi and Zayd Jastaniah and Wael Y. Alsayed and Dahlia Mirdad and Reyouf Almughamsi and Abdulkareem Fayoumi and Humaira Waseem and Amber Hassan},
  year = {2026},
  journal = {Oncologie},
  doi = {10.1515/oncologie-2025-0535},
  url = {https://doi.org/10.1515/oncologie-2025-0535}
}

RIS

TY  - JOUR
TI  - Association of adjuvant chemotherapy regimen with serial CA-125 kinetics (KELIM framework) and progression-free survival after cytoreductive surgery for ovarian cancer: a retrospective cohort study
AU  - Ahmad Alwazzan
AU  - Hisham Nasief
AU  - Razan Amjad
AU  - Rayyan Hasanain
AU  - Huda Altoukhi
AU  - Zayd Jastaniah
AU  - Wael Y. Alsayed
AU  - Dahlia Mirdad
AU  - Reyouf Almughamsi
AU  - Abdulkareem Fayoumi
AU  - Humaira Waseem
AU  - Amber Hassan
PY  - 2026
JO  - Oncologie
DO  - 10.1515/oncologie-2025-0535
UR  - https://doi.org/10.1515/oncologie-2025-0535
ER  -

APA

Alwazzan, A., Nasief, H., Amjad, R., Hasanain, R., Altoukhi, H., Jastaniah, Z., Alsayed, W. Y., Mirdad, D., Almughamsi, R., Fayoumi, A., Waseem, H., & Hassan, A. (2026). Association of adjuvant chemotherapy regimen with serial CA-125 kinetics (KELIM framework) and progression-free survival after cytoreductive surgery for ovarian cancer: a retrospective cohort study. Oncologie. https://doi.org/10.1515/oncologie-2025-0535

Source records

crossref · retrieved 2026-09-26T11:55:04.126Z